Year: 2023

Vital Releases Doctor-to-Patient Translator That Uses AI and LLMs to Transform Medical Jargon Into Simple, Accurate Content for Patients

Innovative new capability translates complex doctor's notes, radiologist reads, discharge summaries, test results and more into a 5th-grade reading levelCLAYMONT,...

Virogentics, Inc. Receives Permit for Export to Africa of the ITV-1 Immunotherapy Solidifying the Scheduled Administration of the Treatment

Reports on Business combination agreement progressALLEN, TX / ACCESSWIRE / August 8, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Virogentics, Inc....

Hemostemix Submits Its Retrospective Heart Study to Leading Stem Cell Journal and Has Prepared Its CLI Phase II Clinical Trial Manuscript for Peer Review

Calgary, Alberta--(Newsfile Corp. - August 8, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce...

error: Content is protected !!